Cultura de seguridad del paciente en directivos y gestores, análisis (Aragón) Tesis doctoral http://t.co/DzSLaODDZq v @pasperper #SegPac
— Sano y salvo (@sanoysalvoblog) January 6, 2014
Miedo y culpa, tóxicos para la seguridad del paciente y la calidad. Las inspecciones del NHS http://t.co/7iULVOJn0S v @mellojonny #SegPac
— Sano y salvo (@sanoysalvoblog) January 6, 2014
(No Gracias) El sobrediagnóstico: un problema sistémico http://t.co/rx2r4Cb3df #SegPac
— Sano y salvo (@sanoysalvoblog) January 6, 2014
(BMJ) Polypharmacy: thoughtful or random? http://t.co/mzymtUCYqB #PtSafety
— Sano y salvo (@sanoysalvoblog) January 6, 2014
¿Qué deben hacer los pacientes si olvidan una toma de un medicamento?: El boletín de información sobre... http://t.co/pqJYpLi70m #SegPac
— Sano y salvo (@sanoysalvoblog) January 6, 2014
RT @AdverseEvent FDA to Assess Stroke, Hemorrhage Outcomes for Anticoagulant Drugs Dabigatran and Warfarin http://t.co/gDxnBqyKlx #PtSafety
— Sano y salvo (@sanoysalvoblog) January 6, 2014
SOBREDIAGNÓSTICO: cuando las buenas intenciones coincidencon los intereses creados — un ensayo de Iona Heath http://t.co/OmN32wToc5 #SegPac
— Sano y salvo (@sanoysalvoblog) January 7, 2014
RT @AdverseEvent Analysis Determines Levels Sexual Dysfunction in Second Generation Antidepressants http://t.co/HrNBqPvZQc #PtSafety
— Sano y salvo (@sanoysalvoblog) January 7, 2014
Breast Cancer Screenings: What We Still Don’t Know http://t.co/twSJbRrMqs
— Iona Heath (@iona_heath) January 2, 2014
MEDICATION ADHERENCE: We Didn’t Ask and They Didn’t Tell http://t.co/t0W96IeQuF vía @ernestob #PtSafety
— Sano y salvo (@sanoysalvoblog) January 8, 2014
Are drugs companies transparent enough about their products? http://t.co/kouyhYyGC5 entrevista a @fgodlee #AllTrials #PtSafety
— Sano y salvo (@sanoysalvoblog) January 8, 2014
FDA warns of possible harm from exceeding recommended dose of otc #sodium #phosphate products to treat constipation. http://t.co/hJIwIfjYTL
— FDA Drug Information (@FDA_Drug_Info) January 8, 2014
(BMJ) Quality of reporting in systematic reviews of adverse events: systematic review http://t.co/3Y35xnXBAI #PtSafety
— Sano y salvo (@sanoysalvoblog) January 8, 2014
EvidenceBased de-implementation for contradicted, unproven, and aspiring healthcare practices http://t.co/ibRwcJZZeN vía @ernestob #PtSafety
— Sano y salvo (@sanoysalvoblog) January 8, 2014
The Moral Imperative To Disclose Medical Error: Doing The Right Thing http://t.co/aGbnUp1XAp vía @lramosneira #PtSafety
— Sano y salvo (@sanoysalvoblog) January 8, 2014
(Neurology) In utero exposure to levetiracetam vs valproate. Development and language at 3 years of age http://t.co/3RY3XnJnMn #PtSafety
— Sano y salvo (@sanoysalvoblog) January 9, 2014
Antipsychotic Drug Exposure and Risk of Venous Thromboembolism: Meta-Analysis of Observational Studies http://t.co/skDje3eOrh #PtSafety
— Sano y salvo (@sanoysalvoblog) January 9, 2014
Declaración final de #NoSinEvidencia http://t.co/6R5YKUe9vu #SegPac
— Sano y salvo (@sanoysalvoblog) January 10, 2014
(NPS) PPIs in older people — do you know the risks? http://t.co/SXkFFIYeXF #PtSafety
— Sano y salvo (@sanoysalvoblog) January 10, 2014
Ranelato de estroncio (Osseor,Protelos):la revisión europea concluye que el balance beneficio-riesgo es desfavorable http://t.co/S2n6pj8B3o
— AEMPS (@AEMPSGOB) January 10, 2014
Surprised this @NPSmedicinewise review of PPI risks doesn't mention interstitial nephritis. http://t.co/hVBaeovnYe @sanoysalvoblog
— David Juurlink (@DavidJuurlink) January 10, 2014
(EMA) PRAC recommends suspending use of Protelos/Osseor http://t.co/vhntpjUrtx #PtSafety
— Sano y salvo (@sanoysalvoblog) January 10, 2014
New Study Links Certain Antibiotics to Peripheral Neuropathy, Guillain–Barré Syndrome http://t.co/uJx23B4Dr3 #PtSafety
— Sano y salvo (@sanoysalvoblog) January 10, 2014
#FDA issues new safety warning about OTC sodium phosphate laxatives http://t.co/CwU3QEHTnz
— news@JAMA (@newsatJAMA) January 10, 2014
MT @DavidJuurlink: Great idea: Want your next fentanyl prescription? Return your used patches first. http://t.co/C2yPeeDmRY #PtSafety
— Sano y salvo (@sanoysalvoblog) January 11, 2014
Clinical human factors group has follow up "how to guide" that highlights need 2 integrate #humanfactors into #design http://t.co/069FTxkOsO
— Dr Shelly Jeffcott (@drjeffcott) December 17, 2013
*El equipo que mantiene @sanoysalvoblog está compuesto por Cecilia Calvo Pita @cecilicp y Jesús Palacio Lapuente @je_pala.
Realiza la publicación de estas selecciones Txema Coll Benejam @txemacoll.
No hay comentarios:
Publicar un comentario